CTLA-4 gene variant -1661A>G may predict the onset of endocrine adverse events in metastatic melanoma patients treated with ipilimumab

Italian Melanoma Intergroup (IMI)

Research output: Contribution to journalLetter

Original languageEnglish
Pages (from-to)59-61
Number of pages3
JournalEuropean Journal of Cancer
Volume97
DOIs
Publication statusPublished - Jul 1 2018

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this